Imbruvica (ibrutinib) Capsules

Award Notice Posted

Solicitation number
VA797P14R0033
Agency
Awarded
to Pharmacyclics, Inc.
Set-aside
No set-aside

Opportunity facts

Contract number
VA797P14C0014 Federal IDV award
PSC
Not on record
Place of performance
Department of Veterans Affairs 1st Avenue, One Block North of Cermak Rd. Building 37 Hines, IL 60141 60141 US

Notice details come from SAM.gov. Updated .

Notice text

Added: May 19, 2014 12:23 pm The National Acquisition Center intends to enter into a sole-source contract with Pharmacyclics Inc. for the procurement of Imbruvica (Ibrutinib) a branded (patented) product used for the treatment of patients with chronic lymphocytic leukemia (CLL). In addition it is also indicated for the treatment of patients with mantle cell lymphoma (MCL). This action is to contract for the identified drug which is currently sourced from a non-designated Trades Agreement Act (TAA) country. The product is available from only one source, Pharmacyclics. This notice of intent is not a request for competitive proposals as Imbruvica (Ibrutinib) is protected by patent. It is anticipated a contract will be awarded for a base plus four one-year options. All inquiries and concerns must be addressed in writing to the email address stated herein, Attn: Youlanda.Duggar@va.gov. The Government anticipates an award date on or before July 3, 2014.

Files

File Type Posted
VA797P-14-R-0033-000.docx DOCX document

Notice history

Notice Type Posted
Imbruvica This contract is for a base plus four one-year options. The estimated award is the total value over a five year period if all option years are exercised. Latest Award Notice
This notice Original Award Notice

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity
Try for free Login